From GlobeNewswire: 2025-06-18 10:04:00

The global Geriatric Medicines Market is projected to reach USD 1,701.91 Bn by 2032, with a CAGR of 6.8% from 2025. The geriatric population is driving demand for specialized treatments, although generic drugs could pose a challenge. North America and Asia Pacific show promising growth in the market. Elderly populations are increasingly in need of age-related medications due to rising chronic diseases. AI integration is transforming the market by improving diagnostics and personalized care. Personalized medicine for the elderly and advancements in drug development are expected to drive market growth. The high cost of geriatric drugs remains a barrier to market expansion, especially in low-income countries. The rise in chronic diseases among the elderly is fueling demand for geriatric medicines, with an emphasis on preventive care. Emerging trends include tailored treatments, drug advancements, and an increase in geriatric healthcare services. Key players in the market include Eli Lilly, Pfizer, AbbVie, and Janssen Pharmaceuticals. Recent FDA approvals and global initiatives are influencing market growth.

For more information on the Geriatric Medicines Market, visit https://www.coherentmarketinsights.com/insight/request-sample/6864.



Read more at GlobeNewswire: Geriatric Medicines Market Growing Elderly Population and